Quick Answer
KALA BIO, Inc. reported Operating Income of -$40.98 million for fiscal year 2024.
KALA BIO, Inc. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2024 | -$40.98M | -3.3% |
| 2023 | -$39.66M | +51.5% |
| 2022 | -$81.71M | +37.3% |
| 2021 | -$130.25M | -35.3% |
| 2020 | -$96.23M | -9.1% |
| 2019 | -$88.22M | -36.3% |
| 2018 | -$64.72M | -62.3% |
| 2017 | -$39.88M | -22.1% |
| 2016 | -$32.67M | -104.9% |
| 2015 | -$15.95M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$7.24M | +27.5% | +34.4% |
| June 30, 2025 | -$11.03M | -14.8% | -3.4% |
| March 31, 2025 | -$10.67M | +10.6% | -6.8% |
| September 30, 2024 | -$9.99M | -14.0% | -4.0% |
| June 30, 2024 | -$9.61M | -0.1% | +19.5% |
| March 31, 2024 | -$11.93M | -2.1% | -36.2% |
| September 30, 2023 | -$8.76M | +39.9% | +8.7% |
| June 30, 2023 | -$9.60M | +63.0% | +17.8% |
- KALA BIO, Inc. showed a decrease of -3.3% in Operating Income compared to the prior fiscal year.
- Over the 2015–2024 period, KALA BIO, Inc.’s operating income has declined by 157.0% (from -$15.95 million to -$40.98 million).
- The most recent figure is from KALA BIO, Inc.’s fiscal year 2024 report (Form 10-K), filed with the SEC on March 31, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: